Steve Tutewohl Biography and Net Worth

COO of Evolent Health

As Chief Executive Officer, Evolent Health Services, Steve Tutewohl leads Evolent Health’s solution focused on partnerships with health plans and risk-bearing organizations looking to simplify their administrative and clinical operations. Steve has spent most of the last 20 years as part of the Health Plan Services executive team (at former Valence Health) and played a key role in building out its third-party administration capabilities. Additionally, Steve is a fully credentialed actuary and has led teams accountable for actuarial, analytics, population health software and account management.

Prior to joining Evolent, Steve led the business intelligence group for Dean Health Plan in Wisconsin and was an actuarial consultant with PricewaterhouseCoopers in Chicago. Steve received his B.S. in risk management, math and actuarial science from the University of Wisconsin.

How do I contact Steve Tutewohl?: The corporate mailing address for Mr. Tutewohl and other Evolent Health executives is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. Evolent Health can also be reached via phone at (571) 389-6000 and via email at investorrelations@evolenthealth.com. Learn More on Steve Tutewohl's contact information.
Has Steve Tutewohl been buying or selling shares of Evolent Health?: Steve Tutewohl has not been actively trading shares of Evolent Health within the last three months. Most recently, Steve Tutewohl sold 1,918 shares of the business's stock in a transaction on Thursday, March 3rd. The shares were sold at an average price of $27.30, for a transaction totalling $52,361.40. Learn More on Steve Tutewohl's trading history.
Who are Evolent Health's active insiders?: Evolent Health's insider roster includes Seth Blackley (Co-Founder, CEO & Director), Mary Duffy (Director), Diane Holder (Director), John Johnson (CFO), Daniel Mccarthy (President), Emily Rafferty (COO), Cheryl Scott (Director), Steve Tutewohl (COO), Jonathan Weinberg (General Counsel), and Frank Williams (Chairman). Learn More on Evolent Health's active insiders.
Are insiders buying or selling shares of Evolent Health?: In the last year, Evolent Health insiders bought shares 4 times. They purchased a total of 74,000 shares worth more than $666,315.20. In the last year, insiders at the technology company sold shares 5 times. They sold a total of 307,291 shares worth more than $9,290,384.77. The most recent insider tranaction occured on March, 6th when Director Diane Holder bought 2,735 shares worth more than $25,517.55. Insiders at Evolent Health own 1.6% of the company. Learn More about insider trades at Evolent Health.
Information on this page was last updated on 3/6/2025.

Steve Tutewohl Insider Trading History at Evolent Health

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction
3/3/2022	Sell	1,918	$27.30	$52,361.40
3/1/2022	Sell	5,388	$27.41	$147,685.08
2/3/2022	Sell	1,707	$22.85	$39,004.95
2/1/2022	Sell	6,313	$23.47	$148,166.11
9/1/2021	Sell	13,553	$25.05	$339,502.65
8/3/2021	Sell	25,030	$23.02	$576,190.60
7/8/2021	Sell	200	$22.00	$4,400.00
5/3/2021	Sell	19,295	$21.48	$414,456.60

Steve Tutewohl Buying and Selling Activity at Evolent Health

Evolent Health Company Overview

Evolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.

Today's Range

Now: $9.59

$9.38

$9.68

50 Day Range

MA: $9.81

$8.58

$10.71

2 Week Range

Now: $9.59

$8.35

$33.63

Volume

1,440,108 shs

Average Volume

2,216,408 shs

Market Capitalization

$1.12 billion

P/E Ratio

N/A

Dividend Yield